SCHEMBL17548686

SCHEMBL17548686

C#CCCc1c(CCCC)[nH]c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.52
CHRNA7 P36544 1/20 0.52
CHRNA4 P43681 1/20 0.52
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 6/20 0.45
HPGD P15428 6/20 0.45
HSD17B10 Q99714 4/20 0.45
TSHR P16473 4/20 0.43
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2C19 P33261 2/20 0.43
MTNR1A P48039 2/20 0.43
MTNR1B P49286 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17548685 0.89 CHRNB2 (0.56) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL28674730 0.83 CHRNB2 (0.59) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL28987798 0.83 CHRNB2 (0.58) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL5409935 0.82 CHRNB2 (0.60) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL31091563 0.80 CHRNB2 (0.59) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
Cyanide SCHEMBL28564062 0.80 CHRNB2 (0.52) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL19734471 0.79 CHRNB2 (0.55) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL5465366 0.79 CHRNB2 (0.54) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL7089878 0.77 CHRNB2 (0.55) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1
SCHEMBL19734470 0.75 CHRNB2 (0.54) CHRNB2CHRNA7CHRNA4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9745266-B2 Indoline alkaloid compounds THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2017-08-29 US disclosed
US-20160060219-A1 INDOLINE ALKALOID COMPOUNDS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060219-A1 INDOLINE ALKALOID COMPOUNDS INMT, IDO1, SRM CHRNB2 2503/4885CHRNA7 1139/4885CHRNA4 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.